The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?

  • American Review of Respiratory Disease, April 2018, American Thoracic Society
  • DOI: 10.1164/rccm.201709-1840pp

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1164/rccm.201709-1840pp

The following have contributed to this page: Olivier Sitbon and Professor Olivier SITBON